Company news
Shanghai Serum Bio-Technology Co., Ltd. news in 2025
Shanghai Serum Bio-Technology Co., Ltd.'s news releases, calls and decks from 2025, newest first.
Announcement on Changing Signatory Certified Public Accountant
December 25, 2025
Announcement on Attending Three-Quarter Report Collective Performance Briefing of Listed Companies in Shanghai Jurisdiction in 2025
November 3, 2025
Report for Q3 2025
October 27, 2025
Announcement on Implementation of Semi-annual Dividend Distribution for 2025
September 19, 2025
Announcement on Attending Semi-annual Collective Performance Briefing for Enterprises in Biological Products and CXO Industries on SSE STAR Market 2025
September 4, 2025
Announcement on Listing and Circulation of Restricted Shares in Initial Public Offering
September 3, 2025
Special Report on Semi-annual Deposit and Actual Use of Raised Funds in 2025
August 25, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
August 11, 2025
Notice on Convening the 1st Extraordinary General Meeting in 2025
July 24, 2025
Announcement on Closing Some Investment Projects Financed by Raised Funds and Using Residual Raised Funds to Permanently Supplement Current Capital and Canceling Relevant Special Accounts for Raised Funds
June 18, 2025
Announcement on Implementation of Dividend Distribution for 2024
May 27, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 16, 2025
Announcement on the Remuneration Plan for Directors, Supervisors and Senior Management Members in 2025
April 25, 2025
Announcement on Convening Performance Meeting for 2024 and 1st Quarter of 2025
April 21, 2025
Announcement on Changing Project Quality Control Reviewer of Audit Institution
April 8, 2025
Announcement on Using Some Temporarily Idle Raised Funds for Cash Management
March 20, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 25, 2025
Announcement on Change of Chief Financial Officer
February 7, 2025